Table 4. Numbers of significantly regulated genomic loci, by CC-486 dosing schedule.* .
Cycle 1—Day 15 | Cycle 1—Day 22 | Cycle 1 End (Day 28±1) | ||||
---|---|---|---|---|---|---|
Cycle 1 | Up | Down | Up | Down | Up | Down |
CC-486 300 mg QD x 14 days (n = 18) | 0 | 88 | 0 | 434 | 0 | 133 |
CC-486 300 mg QD x 21 days (n = 17) | 0 | 1470 | 0 | 2807 | 0 | 1483 |
CC-486 200 mg BID x 21 days (n = 5) | 1 | 5089 | 0 | 5586 | 2 | 4447 |
* No loci were significant at the 0.05 level for the CC-486 200 mg BID x14 days dosing regimen, mainly due to small sample size (n = 3).
BID = twice daily; QD = once daily